Emergency Contraceptive Pills Market

Emergency Contraceptive Market is Expected to Represent US$ 1.2 Bn in Global
Revenues by 2022
Negative perceptions about emergency contraception are likely to hamper the sales of
“morning after” pills in the future. Despite the high accessibility of emergency contraceptive
pills, followed by rising awareness of highly-effective birth control methods, incidences of
unwanted or mistimed pregnancies persist. Moreover, high risk of morbidity and mortality
associated with these pregnancies is disintegrating the fabric of urban cultures.
While unprotected sex continues to be a matter of mutual consent, obstetricians advise
couples to opt for emergency contraception, particularly in healthcare settings with lack of
accessibility to proper & safe abortion. Since unprotected sex also increases the risks of
sexually transmitted infections, the ineffectiveness of emergency contraceptive pills in
protection from venereal diseases continues to be a concern for manufacturers. Sales of
emergency contraceptive pills are also being adversely impacted by unresolved side effects
of emergency contraception – which include time constraint for intake, heavy vomiting,
muscle spasms, and feeling nauseous.
View and Download TOC of Emergency Contraceptive Pills Market Research Report @
https://www.persistencemarketresearch.com/market-research/emergency-contraceptive-pillsmarket/toc
According to Persistence Market Research’s newly-published study, the global sales of
emergency contraceptive pills are expected to dwindle in the next five years. By the end of
2022, the global market for emergency contraceptive pills will have reached a value of just
over US$ 1,230 Mn. During the forecast period, 2017-2022, the global emergency
contraceptive pill market is anticipated to exhibit sluggish growth and reflect less than 3%
CAGR.
The report segments the global market for emergency contraceptive pills on the basis of
products, among which combination pills are expected to dominate the market revenues. In
the foreseeable future, combination pills will witness relatively higher sales in the global
market, primarily due to their health benefits in reducing risk of ectopic pregnancy. In 2017,
nearly two-fifth of revenues procured in the global emergency contraceptive pills market
will be contributed by global sales of combination pills.
Request and Download Sample Report @
https://www.persistencemarketresearch.com/samples/18343
On the contrary, use of estrogen pills for emergency contraception will lose traction. Over
the forecast period, estrogen pills as a product in the global emergency contraceptive pills
market will exhibit revenue growth at just 1.5% CAGR. Demand for progesterone pills is
also expected to drop, particularly owing to their side effects which include joint pain, hot
flashes, and diarrhea.
Key findings from the report indicate drug stores and hospital pharmacies as the two largest
sales channels for emergency contraceptive pills. In 2017, sales of emergency contraceptive
pills through these channels is expected to account for collective global revenue share of
nearly 70%.
Buy Full Emergency Contraceptive Pills Market Report @
https://www.persistencemarketresearch.com/checkout/18343

Negative perceptions about emergency contraception are likely to hamper the sales of “morning after” pills in the future

Download Report